Search results

Found 405 pages
AUTHOR: John Pinching

Results per page

10 20 50 100

Sort by

Relevance Date

30 Jan 2023:

Milestone product launch for Kelso Pharma

Acepiro tablets for respiratory diseases will be available across the UK prescription market - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/milestone_product_launch_for_kelso_pharma_1486054

27 Jan 2023:

Orbsen announces results from Nephstrom trial

Clinical study is researching patients with diabetes and advanced chronic kidney disease - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/orbsen_announces_results_from_nephstrom_trial_1485975

31 Jan 2023:

AlzeCure’s neuropathic pain candidate study reaches crucial phase

Research concerns ACD440 – a non-opioid drug which treats peripheral neuropathic pain - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/alzecures_neuropathic_pain_candidate_study_reaches_crucial_phase_1486091

26 Jan 2023:

Netris Pharma starts hepatocellular carcinoma study

Trial will evaluate efficacy of anti-netrin-1 antibody candidate NP137 in combination with Atezo-bev - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/netris_pharma_starts_hepatocellular_carcinoma_study_1485912

24 Jan 2023:

Memo Therapeutics reveals positive AntiBKV data

Therapy involves renal transplant patients requiring treatment of BK polyomavirus infection - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/memo_therapeutics_reveals_positive_antibkv_data_1485738

31 Jan 2023:

Sanofi’s efanesoctocog alfa may be game-changer for haemophilia A…

Phase 3 study demonstrated that efanesoctocog alfa met both primary and secondary endpoints - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/sanofis_efanesoctocog_alfa_may_be_game-changer_for_haemophilia_a_patients_1486092

25 Jan 2023:

Evgen completes three cohorts for SFX-01

New enteric-coated tablet formulation will now replace the previous prototype capsule - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/evgen_completes_three_cohorts_for_sfx-01_1485814

20 Jan 2023:

NICE recommends Takeda’s Ninlaro triplet regimen

Therapy involves patients living with relapsed or refractory multiple myeloma - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nice_recommends_takedas_ninlaro_triplet_regimen_1485592

30 Jan 2023:

Medicines policy may be halting Government’s drive for growth

Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023 - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/medicines_policy_may_be_halting_governments_drive_for_growth_1486055

27 Jan 2023:

NICE recommends Alexion’s asfotase alfa across England

Therapy involves patients with paediatric-onset hypophosphatasia – a rare bone disease - News - PharmaTimes

by John Pinching

https://www.pharmatimes.com/news/nice_recommends_alexions_asfotase_alfa_across_england_1485973